Table 5 Demographic and Baseline Characteristics of Patients that Used Telemedicine during COVID − 19 Pandemic

Age, mean ± SD

40 ± 12.8

Female, n (%)

75 (92.6)

Rheumatic Condition, n (%)

 Systemic Lupus Erythematosus

57 (70.4)

 Rheumatoid Arthritis

12 (14.8)

 Psoriatic Arthritis

1 (1.2)

 Ankylosing Spondylitis

3 (3.7)

 Sjorgen Syndrome

6 (7.4)

 Systemic Sclerosis/Scleroderma

4 (4.9)

 Vasculitis

2 (2.5)

Medications, n (%)

 Biologic Agent

3 (3.7)

 Non-Biologic DMARD

65 (80.2)

 Anti-Malaria

16 (19.8)

 Glucocorticoid

63 (77.8)

Preferred modality, n (%)

 Chat/text

56 (69.1)

 Video-conference

44 (54.3)

 Online Form Face-to-Face Appointment

27 (33.3)

Prefer Using Telemedicine during COVID-19 Pandemic, n (%)

44 (54.3)

Prefer Using Telemedicine after COVID-19 Pandemic, n (%)

33 (40.7)